Evidence map›Paper›PMID 42489338›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Deep Learning Prediction of O-Glycopeptide Tandem Mass Spectra Enhances O-Glycoproteomics.

Yu Zong, Yuxin Wang, Liang Qiao

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yu ZongDepartment of Chemistry, and Minhang Hospital, Fudan University, Shanghai, China.
Yuxin WangDepartment of Computer Science, and Institute of Modern Languages and Linguistics, Fudan University, Shanghai, China.
Liang QiaoDepartment of Chemistry, and Minhang Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-6233-8459

Funding

National Natural Science Foundation of China 22525401National Natural Science Foundation of China 92578107Science and Technology Commission of Shanghai Municipality 23JS1400100
6 · The paper itself

Abstract

Protein glycosylation, a post-translational modification involving the attachment of glycans to proteins, plays critical roles in numerous physiological and pathological cellular functions. Characterization of protein glycosylation is one of the most challenging problems due to the high heterogeneity of glycosites and glycan structures. Recently, deep learning has been adopted to predict N-glycopeptide tandem mass spectrometry (MS/MS) spectra and exhibited a promising effect in N-glycoproteomics analysis. However, current deep learning frameworks struggle to accurately predict O-glycopeptide MS/MS spectra due to the complexity of O-glycopeptides and the limited availability of training data. In this study, we introduce DeepGPO, a deep learning framework for the prediction of O-glycopeptide MS/MS spectra. The DeepGPO incorporates a Transformer module alongside two graph neural network modules designed for handling branched glycans. To address the issue of data scarcity in O-glycoproteomics, various training methods are adopted in DeepGPO, such as the introduction of training weights for different MS/MS spectra and the adoption of pre-training strategies. With the predicted MS/MS, O-glycosylation sites can be localized even in the absence of site-determining ions. Currently, DeepGPO supports both mono- and double-O-glycosylated peptides. It shows promising application in clinical human O-glycoproteomics. We anticipate that DeepGPO will inspire future advancements in glycoproteomics research.

Indexed as

deep learninggraph neural networkmass spectrometryO‐glycoproteomicsO‐glycosite localization

Identifiers

PMID42489338
PMCPMC13393516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.